Literature DB >> 12534345

Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.

Hidetaka Uramoto1, Hiroto Izumi, Gunji Nagatani, Haruki Ohmori, Naofumi Nagasue, Tomoko Ise, Takeshi Yoshida, Kosei Yasumoto, Kimitoshi Kohno.   

Abstract

The CCAAT-binding transcription factor (CTF)/nuclear factor I (NF-I) group of cellular DNA-binding proteins recognizes the sequence GCCAAT and is implicated in eukaryotic transcription, as well as DNA replication. Molecular analysis of human CTF/NF-I cDNA clones revealed multiple mRNA species that contain alternative coding regions, apparently as a result of differential splicing. Expression and functional analysis established that individual gene products can bind to GCCAAT recognition sites and serve as both promoter-selective transcriptional activators and initiation factors for DNA replication. The interaction between CTF2 and p53/p73 was shown to modulate their ability to regulate transcription of their respective target genes. In the present paper, we report that p53 down-regulates the activity of the high mobility group 1 (HMG1) gene promoter, whereas p73alpha up-regulates the activity of this promoter. Furthermore, CTF2 transactivates p53-induced p21 promoter activity, but inhibits p73alpha-induced p21 promoter activity. Using deletion mutants, we found that the DNA-binding domains of both p53 and p73alpha are required for physical interaction with CTF2 via the regions between amino acid residues 161 and 223, and 228 and 312 respectively. CTF2 enhances the DNA-binding activity of p53 and inhibits the DNA-binding activity of p73alpha. These results provide novel information on the functional interplay between CTF2 and p53/p73 as important determinants of their function in cell proliferation, apoptosis, DNA repair and cisplatin resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12534345      PMCID: PMC1223307          DOI: 10.1042/BJ20021646

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Role of p53 in cellular response to anticancer nucleoside analog-induced DNA damage.

Authors:  L Feng; G Achanta; H Pelicano; W Zhang; W Plunkett; P Huang
Journal:  Int J Mol Med       Date:  2000-06       Impact factor: 4.101

2.  Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expression.

Authors:  T Okamoto; H Izumi; T Imamura; H Takano; T Ise; T Uchiumi; M Kuwano; K Kohno
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

3.  P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line.

Authors:  F Vikhanskaya; S Marchini; M Marabese; E Galliera; M Broggini
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.

Authors:  G Nagatani; M Nomoto; H Takano; T Ise; K Kato; T Imamura; H Izumi; K Makishima; K Kohno
Journal:  Cancer Res       Date:  2001-02-15       Impact factor: 12.701

6.  Interaction with p53 enhances binding of cisplatin-modified DNA by high mobility group 1 protein.

Authors:  T Imamura; H Izumi; G Nagatani; T Ise; M Nomoto; Y Iwamoto; K Kohno
Journal:  J Biol Chem       Date:  2000-12-05       Impact factor: 5.157

7.  Adenovirus DNA replication in vitro: identification of a host factor that stimulates synthesis of the preterminal protein-dCMP complex.

Authors:  K Nagata; R A Guggenheimer; T Enomoto; J H Lichy; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

Review 8.  P63 and P73: P53 mimics, menaces and more.

Authors:  A Yang; F McKeon
Journal:  Nat Rev Mol Cell Biol       Date:  2000-12       Impact factor: 94.444

9.  Structure and function of the adenovirus origin of replication.

Authors:  D R Rawlins; P J Rosenfeld; R J Wides; M D Challberg; T J Kelly
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

Review 10.  The p53/p63/p73 family of transcription factors: overlapping and distinct functions.

Authors:  M Levrero; V De Laurenzi; A Costanzo; J Gong; J Y Wang; G Melino
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  17 in total

Review 1.  High-mobility group box 1, oxidative stress, and disease.

Authors:  Daolin Tang; Rui Kang; Herbert J Zeh; Michael T Lotze
Journal:  Antioxid Redox Signal       Date:  2011-04-01       Impact factor: 8.401

2.  p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) Analyses.

Authors:  Sabine Hünten; Markus Kaller; Friedel Drepper; Silke Oeljeklaus; Thomas Bonfert; Florian Erhard; Anne Dueck; Norbert Eichner; Caroline C Friedel; Gunter Meister; Ralf Zimmer; Bettina Warscheid; Heiko Hermeking
Journal:  Mol Cell Proteomics       Date:  2015-07-16       Impact factor: 5.911

Review 3.  High-mobility group box 1 and cancer.

Authors:  Daolin Tang; Rui Kang; Herbert J Zeh; Michael T Lotze
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

4.  ASPP1 and ASPP2: common activators of p53 family members.

Authors:  Daniele Bergamaschi; Yardena Samuels; Boquan Jin; Sai Duraisingham; Tim Crook; Xin Lu
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

Review 5.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

Review 6.  The implication and potential applications of high-mobility group box 1 protein in breast cancer.

Authors:  Moonindranath Sohun; Huiling Shen
Journal:  Ann Transl Med       Date:  2016-06

7.  p73-Binding Partners and Their Functional Significance.

Authors:  Toshinori Ozaki; Natsumi Kubo; Akira Nakagawara
Journal:  Int J Proteomics       Date:  2011-01-13

Review 8.  Role of miRNA let-7 and its major targets in prostate cancer.

Authors:  Siegfried Wagner; Anaclet Ngezahayo; Hugo Murua Escobar; Ingo Nolte
Journal:  Biomed Res Int       Date:  2014-09-03       Impact factor: 3.411

9.  Structural and functional implications of p53 missense cancer mutations.

Authors:  Yuhong Tan; Ray Luo
Journal:  PMC Biophys       Date:  2009-06-26

10.  Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis.

Authors:  Melda Tozluoğlu; Ezgi Karaca; Turkan Haliloglu; Ruth Nussinov
Journal:  Nucleic Acids Res       Date:  2008-07-26       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.